Home Health Rare diseases, Aifa approves new therapy for paroxysmal nocturnal hemoglobinuria

Rare diseases, Aifa approves new therapy for paroxysmal nocturnal hemoglobinuria

by admin

An ultra-rare blood disease, very debilitating and which can cause – in severe cases – even death. It is paroxysmal nocturnal hemoglobinuria and now for the patients who suffer from it comes a new possibility of treatment. The Italian Medicines Agency, in fact, has approved ravulizumab which, thanks to its administration every two months, reduces the impact of treatment on patients, improving their quality of life.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy